Combining the programs from Newport Hospital and Rhode Island Hospital allows for additional treatment options.

In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

The resulting video makes for quite the sight, as the surgery team behind the plastic sanitary screen sat listening in wonder ...

My grandfather started to shuffle his feet and have trouble with basic things like buttoning his shirt a few years ago. Subtle brain changes had been silently ...

Alterskrankheit sind soetwas wie die Nebenwirkungen des Alterns. Das Älterwerden ist ein natürlicher Teil des Lebens.

The aggregate gross proceeds to the Company from the offering are expected to be approximately $3.4 million, before deducting the placement agent fees and other offering expenses payable by the ...

The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...

A genetic analysis of blood samples reveals molecular changes in early-stage Parkinson’s patients, offering a non-invasive ...

The article titled Understanding Therapy Services & When to Seek Them features insights from Rehabilitation Expert Kelly ...

Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval, BioSpace looks at ...

Ahead of Little Big Town's Nashville Christmas residency, the chart-topping country artist opens up about her mother's ...

Prebys Ventures announced it has invested $5 million into five San Diego startup companies working on the cutting edge of ...